Market volatility derails Novartis' plan to sell stake in its India arm
Novartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation.
Medical Marketing & Media1d
Novartis names new chief legal and compliance officer as Klaus Moosmayer exits
Karen Hale, who joined Novartis in 2021 as chief legal officer, will take on the new chief legal and compliance officer role.
Medical Dialogues1d
Novartis appoints Karen Hale as Chief Legal and Compliance Officer
Basel: Novartis has announced the appointment of Karen Hale to the expanded role of Chief Legal and Compliance Officer for ...
Novartis appoints Karen Hale, Chief Legal and [...]
Novartis announced today the appointment of Karen Hale to the expanded role of Chief Legal and Compliance Officer for Novartis, effective April 14, 2025. She will continue to report to Vas Narasimhan, ...
Fierce Pharma4d
Novartis' prostate cancer drug Pluvicto wins key FDA nod toward $5B-plus sales target
After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...